COVID arm and PET/FDG imaging

Barrière, Jérôme; Bondouy, M

doi:10.1016/j.bulcan.2021.04.002

Cited by 3 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Barriere et al [11] described the case of a 76-year-old female with ovarian neoplasia who developed oedema without erythema, pain, and a 2 cm painless axillary lymphadenopathy, 5 days after the second dose of Pfizer/BioNTech's vaccine. PET/FDG imaging showed a complete metabolic response to the peritoneal target, but hypermetabolism in the lymph node and in the deltoid muscle was found [11]. Vaccination is the cause of a transient locoregional inflammatory reaction with inflammation of lymph nodes that can induce positive findings on FDG-PET [11].…”

Section: Discussionmentioning

confidence: 99%

“…PET/FDG imaging showed a complete metabolic response to the peritoneal target, but hypermetabolism in the lymph node and in the deltoid muscle was found [11]. Vaccination is the cause of a transient locoregional inflammatory reaction with inflammation of lymph nodes that can induce positive findings on FDG-PET [11]. Is important to know this local reaction to avoid invasive diagnostic and therapeutic procedures [11].…”

Section: Discussionmentioning

confidence: 99%

“…Vaccination is the cause of a transient locoregional inflammatory reaction with inflammation of lymph nodes that can induce positive findings on FDG-PET [11]. Is important to know this local reaction to avoid invasive diagnostic and therapeutic procedures [11].…”

Section: Discussionmentioning

confidence: 99%

“…Wei et al [8] Case series 4 Moderna mRNA-1273 Anshari et al [9] Case report 1 Moderna mRNA-1273 Zengarini et al [12] Case report 1 Moderna mRNA-1273 Kempf et al [13] Case series 3 Moderna mRNA-1273 Barriere et al [11] Case report 1 Cominarty (Pfizer/BioNTech)…”

Section: Author Study Type Number Of Patients Type Of Vaccinementioning

confidence: 99%

“…The reaction after the first administration is not a contraindication to the second administration. However, patients and health care professionals should be aware that this type of reaction may develop more rapidly after the second vaccine dose [10,11].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Erythema Migrans-like COVID Vaccine Arm: A Literature Review

Fasano

Bennardo

Ruffolo³

et al. 2022

JCM

View full text Add to dashboard Cite

COVID Vaccine Arm (CVA) is an adverse drug reaction from mRNA vaccine for SARS-CoV-2. CVA is characterized by erythema and edema on the vaccination site (usually deltoid area) that appears from 5 to 10 days after vaccination and is sometimes associated with itching or pain. The exact etiology of CVA is still unclear, but delayed hypersensitivity against an excipient seems to play an essential role in the pathogenesis of the disease. This work performs a systematic literature review on CVA using three different databases containing articles published until 10 November 2021. The literature review includes eight papers reporting single cases or case series of CVA. Moreover, it also addresses, other cutaneous reactions following COVID 19 vaccinations as well as possible differential diagnosis. CVA migrans-like erythema is characterized by a ring-shaped rash in the injection area, which appears some days after the injection and disappears in about 10 days. This reaction may appear more rapidly in subsequent doses.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Author Study Type Number Of Patients Type Of Vaccinementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Erythema Migrans-like COVID Vaccine Arm: A Literature Review

Fasano

Bennardo

Ruffolo³

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data

Minamimoto

2022

Front. Med.

View full text Add to dashboard Cite

The COVID-19 pandemic has forced people to significantly change their lifestyles and attitudes, and has greatly burdened healthcare delivery systems worldwide. The redistribution of the medical delivery system to maintain normal medical care while responding generously to COVID-19 is a continuing challenge that weighs heavily on medical institutions. Among imaging modalities, chest X-rays and computed tomography (CT) examinations have clearly made a large contribution to treatment of COVID-19. In contrast, it is difficult to express the standpoint of nuclear medicine examinations in a straightforward manner, as the greatest emphasis in this modality has been on how necessary medical care can continue to be provided. Many clinical reports of nuclear medicine examinations related to COVID-19 have been published, and knowledge continues to accumulate. This review provides a summary of the current state of oncology and cardiology positron emission tomography (PET) examinations related to COVID-19, and includes preparation of the nuclear medicine department, trends in PET examinations, specific imaging findings on 18F-fluorodeoxyglucose (FDG) PET/CT, imaging of complications of COVID-19, PET tracers other than FDG, and the effects of vaccines on PET imaging findings.

show abstract

Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review

Minamimoto

Kiyomatsu

2021

GHM

View full text Add to dashboard Cite

COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of COVID-19 vaccination on the management of patients scheduled for FDG-PET/CT in the setting of nationwide mass vaccination.

show abstract

COVID arm and PET/FDG imaging

Cited by 3 publications

References 4 publications

Erythema Migrans-like COVID Vaccine Arm: A Literature Review

Erythema Migrans-like COVID Vaccine Arm: A Literature Review

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data

Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review

Contact Info

Product

Resources

About